Sunday, July 5, 2009

Osteoporosis Home>
News>
FDA: No clear heart problems with osteoporosis meds

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE osteoarthritis of the knee pamphlet.Start here.

FDA: No clear heart problems with osteoporosis meds

(Reuters) UPDATED 2008-11-19

The U.S. Food and Drug Administration (FDA) says there are no heart rhythm problems associated with some osteoporosis medications. The conclusion was based on clinical trials conducted on nearly 40,000 women who were taking bisphosphonates such as Fosamax, Actonel, Boniva, and Reclast. In all four studies, researchers found that abnormal heart rate problems were rare. The FDA indicated that they will continue to monitor reports of abnormal heart rhythm in patients, but they say that patients should continue taking the medication as prescribed. Read full story >

See all Osteoporosis News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on OsteoporosisConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.